Revolution Medicines logo

Executive Director, Global Marketing, PDAC Cancer Strategy & Ops

Revolution Medicines

Any City, USRemotePosted 2 days ago$252,000 - $315,000/year
Full TimeDirector & AboveCommercial & Pharma SalesBiotechnology
Original posting ↗

Summary

We are hiring an Executive Director of Global Commercial Development, reporting to VP Pancreatic Cancers. The role will work within a growing and fluid Global Commercial Development organization. Roles will continuously evolve as the team grows and portfolio priorities shift across multiple indications and assets. The role will have 2-3 direct reports. This position can be based out of Redwood City (CA), Plainsboro (NJ) or remote.

Job description

The Opportunity

We are hiring an Executive Director of Global Commercial Development, reporting to VP Pancreatic Cancers. The role will work within a growing and fluid Global Commercial Development organization. Roles will continuously evolve as the team grows and portfolio priorities shift across multiple indications and assets. The role will have 2-3 direct reports. This position can be based out of Redwood City (CA), Plainsboro (NJ) or remote.

Responsibilities

  • Disease Area Strategy (DAS): Partner with clinical, commercial, medical, access and others to ensure DAS evolves and priorities shift based on latest evidence (internal, competitive). Support prioritization of future assets for development, in-licensing, or combinations. Partner with BD. Be an integrator and conduit of sharing commercial and clinical insights across functions.
  • Multi-year Global Commercialization Plan: Partner and lead with Medical and Market Access to build goals, track goals, and refresh the multi-year commercialization plan for pancreatic cancer that cuts across assets and indications. Share learnings with Lung and CRC teams and coordinate to provide input into cross-tumor plan as well.
  • Enable Brand Pan-Tumor Strategic Elements: Partner with Pancreatic cancer and other tumor commercial and medical teams to align and deliver strategic elements that should be consistent across indications (e.g., overarching positioning, global brand campaign, brand book, consistent dosing/MOA messages). Increase communication and collaboration across multiple teams. Strengthen communication and collaboration across teams and ensure shared strategic elements are implemented consistently.
  • KOL Coordination: Lead global thought leader strategy and coordination: Lead the Senior Director, Global Thought Leader Strategy & Engagement for pancreatic cancers. Guide the development of a strategic approach to global thought leader engagement across the portfolio, coordinate external engagement priorities and relationships, and ensure insights from these interactions inform disease area and commercial strategies.
  • Operational Excellence: Operating in a build-while-scaling environment, this leader will help shape how complex, cross-functional work gets done - bringing clarity, structure, and momentum while partnering closely with senior leaders. Support team meetings for Pancreatic Cancer GCD teams to ensure well-prepared, broad input, and seamless. Plan team building initiatives to build a strong culture. Build team culture, communications, and efficiency. Drive coordinated annual planning processes (e.g., brand planning, forecast updates) for Pancreatic cancers.
  • Lead Pancreatic Cancer teammate providing into early development: Lead director or senior director who coordinates pancreatic commercial input to feed into the early development commercial team. Attend early asset meetings on agenda-driven basis.
  • Lead portfolio narrative and co-positioning strategy projects: Lead the creation and ongoing evolution of a compelling pancreatic cancer portfolio narrative that articulates the disease area opportunity, portfolio strategy, and role of each brand and indication. Drive alignment across brand and indication teams on co-positioning, portfolio-level messages, and the relationship among assets, while ensuring brand strategies remain clearly differentiated and grounded in their clinical profiles.
  • Travel as needed (typically up to 30-45%).

Required Experience, Skills, and Education

  • Bachelor's degree required; advanced degree (MBA, PhD, PharmD, or equivalent) preferred.
  • 15+ years of progressive commercial experience in biotechnology and/or pharmaceuticals, including global strategic marketing or global brand responsibilities; local/affiliate marketing experience required as well.
  • Deep oncology expertise: Strong understanding of oncology drug development and the cancer treatment landscape, including evolving standards of care, clinical practice, and unmet needs. Experience in pancreatic cancer is valuable; broader oncology experience with the ability to quickly build disease-area expertise is also relevant.
  • Ability to interpret clinical evidence: Demonstrated ability to understand clinical data, study design, and development strategy, and to assess their implications for patients, treatment pathways, and the commercial opportunity across assets and indications.
  • Effective partnership with Medical: Experience collaborating with Medical Affairs and Clinical Development as a trusted commercial partner—bringing a distinct commercial perspective, incorporating medical and scientific expertise, and working within clear functional roles and responsibilities.
  • Influence and alignment across teams: Strong ability to build relationships, facilitate constructive discussion, and influence cross-functional stakeholders without relying on direct authority. Can help teams reach a shared interpretation of evidence and translate aligned perspectives into portfolio and brand strategies.
  • Experience supporting commercialization organizations, including involvement in launch readiness, brand planning, operational planning, and capability buildout.
  • Demonstrated Executive Director-level capability, including defining operating models, building scalable organizational capabilities, and driving cross-functional alignment in evolving organizations.
  • Demonstrated track record developing and executing global brand strategies and translating insights into executable plans and deliverables.
  • Launch experience (global, regional, or major market) with responsibility for core brand strategy, messaging, and enabling assets.
  • Proven success partnering with senior commercial, medical, sales, analytics, and access leaders to enable organizational effectiveness.
  • Experience building and scaling high-performing teams and organizational capabilities.
  • Track record of thriving in ambiguous, fast-moving environments with a hands-on, builder mindset.
  • Exceptional communication and interpersonal skills, with the ability to translate complexity into clear and actionable frameworks.
  • Possess an entrepreneurial mindset, with tolerance for ambiguity, strong bias towards action, and a passion for impacting the lives of cancer patients.
  • Proven experience represent companies like Revolution Medicines externally with impressive results and relationships.

Requirements

  • Bachelor's degree required
  • Advanced degree (MBA, PhD, PharmD, or equivalent) preferred
  • 15+ years of progressive commercial experience in biotechnology and/or pharmaceuticals
  • Global strategic marketing or global brand responsibilities
  • Local/affiliate marketing experience required
  • Deep oncology expertise
  • Understanding of oncology drug development and cancer treatment landscape
  • Ability to interpret clinical evidence and study design
  • Experience collaborating with Medical Affairs and Clinical Development
  • Influence and alignment across cross-functional teams
  • Experience supporting commercialization organizations
  • Launch readiness, brand planning, operational planning, capability buildout
  • Executive Director-level capability
  • Track record developing and executing global brand strategies
  • Launch experience (global, regional, or major market)
  • Partnering with senior commercial, medical, sales, analytics, and access leaders
  • Experience building and scaling high-performing teams
  • Thriving in ambiguous, fast-moving environments
  • Exceptional communication and interpersonal skills
  • Entrepreneurial mindset
  • Travel up to 30-45%

Benefits

  • Competitive cash compensation
  • Robust equity awards
  • Strong benefits
  • Learning and development opportunities

Company overview

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.